PURPOSE: The increased efficacy of cancer treatments has led to a greater survival rate of patients with pediatric brain cancers. Therefore, it is imperative to explore the long-term consequences of therapies employed to treat pediatric brain tumors. The goal of this study was to provide a review of literature regarding the downstream psychological and psychiatric consequences experienced by adult survivors of pediatric brain cancer as a result of treatment, tumor type, or tumor location. METHODS: A PubMed MeSH search and additional online database searches were conducted to include pertinent studies that discussed psychological deficits in childhood brain cancer survivors. The studies included were subjected to data extraction to quantify relevant information for further analysis. RESULTS: A total of 17 papers with 5320 pediatric brain tumor patients were incorporated in our review. Mean age at diagnosis (8.13 ± 0.77 years), mean follow-up time (9.98 ± 3.05 years), and male-to-female ratios (1.08:1) were compiled from studies reporting this information. Incidences of depression (19 %), anxiety (20 %), suicidal ideation (10.9 %), schizophrenia and its related psychoses (9.8 %), and behavioral problem (28.7 %) were higher among pediatric brain cancer survivors than in the normal population. Craniospinal radiotherapy and/or surgery corresponded to an increased likelihood of developing adverse deficits. Astrocytomas or other glial tumors were linked to poorer outcomes. CONCLUSION: Physicians treating pediatric brain tumor patients should be aware of the possible consequences associated with treatment. Psychiatric monitoring is warranted in survivors of pediatric brain tumors, but further investigation is needed to elucidate late outcomes regarding tumor type and location.
PURPOSE: The increased efficacy of cancer treatments has led to a greater survival rate of patients with pediatric brain cancers. Therefore, it is imperative to explore the long-term consequences of therapies employed to treat pediatric brain tumors. The goal of this study was to provide a review of literature regarding the downstream psychological and psychiatric consequences experienced by adult survivors of pediatric brain cancer as a result of treatment, tumor type, or tumor location. METHODS: A PubMed MeSH search and additional online database searches were conducted to include pertinent studies that discussed psychological deficits in childhood brain cancer survivors. The studies included were subjected to data extraction to quantify relevant information for further analysis. RESULTS: A total of 17 papers with 5320 pediatric brain tumorpatients were incorporated in our review. Mean age at diagnosis (8.13 ± 0.77 years), mean follow-up time (9.98 ± 3.05 years), and male-to-female ratios (1.08:1) were compiled from studies reporting this information. Incidences of depression (19 %), anxiety (20 %), suicidal ideation (10.9 %), schizophrenia and its related psychoses (9.8 %), and behavioral problem (28.7 %) were higher among pediatric brain cancer survivors than in the normal population. Craniospinal radiotherapy and/or surgery corresponded to an increased likelihood of developing adverse deficits. Astrocytomas or other glial tumors were linked to poorer outcomes. CONCLUSION: Physicians treating pediatric brain tumorpatients should be aware of the possible consequences associated with treatment. Psychiatric monitoring is warranted in survivors of pediatric brain tumors, but further investigation is needed to elucidate late outcomes regarding tumor type and location.
Authors: N K Foreman; P M Faestel; J Pearson; J Disabato; M Poole; G Wilkening; E B Arenson; B Greffe; R Thorne Journal: J Neurooncol Date: 1999-01 Impact factor: 4.130
Authors: Tara M Brinkman; Cori C Liptak; Brian L Delaney; Christine A Chordas; Anna C Muriel; Peter E Manley Journal: J Neurooncol Date: 2013-04-27 Impact factor: 4.130
Authors: Christopher D Turner; Christine A Chordas; Cori C Liptak; Celiane Rey-Casserly; Brian L Delaney; Nicole J Ullrich; Liliana C Goumnerova; R Michael Scott; Heather C Begley; William J Fletcher; Xiaopan Yao; Susan Chi; Mark W Kieran Journal: Pediatr Blood Cancer Date: 2009-09 Impact factor: 3.167
Authors: Ivana M M van der Geest; Wendy van Dorp; Wim C J Hop; Sebastian J C M M Neggers; Andrica C H de Vries; Rob Pieters; Femke K Aarsen; Marry M van den Heuvel-Eibrink Journal: J Pediatr Hematol Oncol Date: 2013-10 Impact factor: 1.289
Authors: Lonnie K Zeltzer; Qian Lu; Wendy Leisenring; Jennie C I Tsao; Christopher Recklitis; Gregory Armstrong; Ann C Mertens; Leslie L Robison; Kirsten K Ness Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-02 Impact factor: 4.254
Authors: Ankie Tan Cheung; William Ho Cheung Li; Laurie Long Kwan Ho; Wei Xia; Godfrey Chi Fung Chan; Joyce Oi Kwan Chung Journal: Support Care Cancer Date: 2020-10-17 Impact factor: 3.603
Authors: Shari L Wade; Gary Bedell; Jessica A King; Michele Jacquin; Lyn S Turkstra; Juliet Haarbauer-Krupa; Jeremy Johnson; Ralph Salloum; Megan E Narad Journal: Rehabil Psychol Date: 2018-07-19
Authors: Ryan Wier; Holly A Aleksonis; Matthew M Pearson; Christopher J Cannistraci; Adam W Anderson; John F Kuttesch; Bruce E Compas; Kristen R Hoskinson Journal: J Neurooncol Date: 2019-05-09 Impact factor: 4.130
Authors: Ineke M Olsthoorn; Alice Ann Holland; Raymond C Hawkins; Allen E Cornelius; Muhammad Usman Baig; Grace Yang; Daniel C Holland; Wafik Zaky; Peter L Stavinoha Journal: Front Neurosci Date: 2022-06-23 Impact factor: 5.152
Authors: E Anne Lown; Farya Phillips; Lisa A Schwartz; Abby R Rosenberg; Barbara Jones Journal: Pediatr Blood Cancer Date: 2015-12 Impact factor: 3.167
Authors: A McCauley Massie; Jonathan Ebelhar; Kristen E Allen; Nicholas P DeGroote; Karen Wasilewski-Masker; Katharine E Brock Journal: Neurooncol Pract Date: 2021-03-12